	Cancer Stem Cell-Targeted Therapies in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Cancer Invest Rebai O, Amri M, Fattouch S. PMID: 42615808 [PubMed - as supplied by publisher]
	Estimating lead time and overdiagnosis in cancer screening programmes: the MOCCI method. Int J Epidemiol Vratanar B, Pohar Perme M. PMID: 42615544 [PubMed - indexed for MEDLINE]
	Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy. JACC CardioOncol Gynnild MN, Lilleaasen AM, Wethal T, Jakobsen EO, Vinje-Jakobsen V, Heck SL, Larsen S, Rösner A, Dalen H, Omland T, Gulati G, Holte E. PMID: 42615453 [PubMed]
	Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer. JACC CardioOncol Moore H, Huppert LA, Moslehi JJ, Yang EH, Hatcher S, Thomas A. PMID: 42615445 [PubMed]
	Strategies for Targeting Mitochondria in the Treatment of Breast Cancer. ACS Pharmacol Transl Sci Wang K, Zheng X, Li Y, Li C, Zhang X, Deng Q, Yang H, Shuai X, Li J, Guo L, Shi J, Bai L. PMID: 42614851 [PubMed]
	A review of ovarian-adnexal reporting and data system and radiomics in ovarian cancer: focus on ultrasound applications. Front Oncol Yu Y, Li H, Liu Y. PMID: 42614437 [PubMed]
	Diagnostic delays, treatment timeliness, and patient experiences in triple-negative breast cancer: a mixed-methods study. Front Oncol Mazo Canola M, Schear R, Housman LT, Backus KV, Hogea C. PMID: 42614301 [PubMed]
	Faith, Culture, and Cancer: A Qualitative Study Exploring Muslim Women's Perspectives on Clinical Trials in the United Kingdom. Health Expect Turner L, Taylor S, Ward A, Ahmed N, Yorke J. PMID: 42613836 [PubMed - indexed for MEDLINE]
	Incidental Discovery of a Fallopian Tube Mesenteric Borderline Serous Tumor During Cesarean Section: A Case Report and Literature Review. Am J Case Rep Tuo Y, Chen D, Geng Y, Liao L. PMID: 42613819 [PubMed - indexed for MEDLINE]
	Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis. J Natl Cancer Inst Massa D, Chiappe E, Delucchi V, Girardi F, Blondeaux E, La Commare M, Guarneri V, Lambertini M, Dieci MV. PMID: 42613756 [PubMed - as supplied by publisher]
	Early Prediction Of Treatment Response To Neoadjuvant Chemotherapy Based On Pre-treatment Ultrasound Radiomics of HER2-positive Breast Cancer Patients by Radiomics-based Model: A Dual-center Retrospective Study. Acad Radiol Du LW, Zha HL, Pan JZ, Du Y, Liu W, Nie CL, Liu XP, Zong M, Zhang B. PMID: 42613278 [PubMed - as supplied by publisher]
	Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group. Int J Gynecol Cancer Pruss M, Hilpert F, Wimberger P, Pfisterer J, du Bois A, Mahner S, Marmé F, Kerkmann M, Sehouli J, de Gregorio N, Hanker L, Woelber L, Holtmann L, Elser G, Harter P, AGO Study Group. PMID: 42613236 [PubMed - as supplied by publisher]
	Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER). Ann Oncol Kalinsky K, Barlow WE, Pathak HB, Puri RV, Mitra A, Home T, Gralow J, Albain KS, Hayes DF, Delaloge S, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Rastogi P, Schott AF, Brain E, Pierga JY, Ferrero JM, Shak S, Tripathy D, Hortobagyi GN, Meric-Bernstam F, Sharma P, Pusztai L, Thompson A, Godwin AK. PMID: 42613139 [PubMed - indexed for MEDLINE]
	Hidden endometrial cancer due to vaginal obliteration associated with lichen sclerosus/lichen planus. BMJ Case Rep Vaz I, Wagner J, Chevalier CA, R Günthert A. PMID: 42613127 [PubMed - indexed for MEDLINE]
	The role of chimeric antigen receptor (CAR) T cell therapy in breast cancer. Int Immunopharmacol Farajzadeh A, Mahmoudi M, Yazdani S, Barati AM, Kheder RK, Rostami O, Fadaee A, Raouf-Rahmati A, Esmaeili SA. PMID: 42612349 [PubMed - as supplied by publisher]
	Potential small-molecule tyrosine kinase inhibitors (TKIs) for the treatment of triple-negative breast cancer (TNBC): Targets, structure-activity relationships, and clinical studies. Eur J Med Chem Yuan H, Li H, Zhou Y, He Z, Yang S, Wang L, He Y, Li L, Yu D, Shi J. PMID: 42612290 [PubMed - as supplied by publisher]
	Construction of Human Breast Cancer Organoids and Comet Assay-Based Quantification of Doxorubicin-Induced DNA Damage. J Vis Exp Wu Y, Jin Z, Du J, Li L, Ouyang W, Yin L, Zhao S, Li J, Li X, Liu SB. PMID: 42612119 [PubMed - indexed for MEDLINE]
	Comprehensive Analysis of m6A Regulators Identifies YTHDF3 as a Promising Prognostic Biomarker for Breast Cancer. J Vis Exp Jin P, Fan Y. PMID: 42612048 [PubMed - indexed for MEDLINE]
	Primary Ovarian Epithelioid Angiosarcoma with Extensive Lymph Node Metastases: A Case Report and Literature Review. J Vis Exp Wu Z, Yang Z, Wang Y, Liu Q. PMID: 42611577 [PubMed - indexed for MEDLINE]
	Prognostic Modeling of Ovarian Cancer Based on Perioperative Anesthesia-Related Drug Target Genes: A Bioinformatics Approach. J Vis Exp Liu Y, Du J, Ban J, Wang J, Liu Y, Zhang G, Xie L. PMID: 42611564 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 333841

Page 1 of 16693



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy